Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE (Tables)

v3.19.3
FAIR VALUE (Tables)
9 Months Ended
Sep. 30, 2019
FAIR VALUE  
Schedule of fair values of financial instruments

The fair values of financial instruments were as follows (dollars in millions):

September 30, 2019

December 31, 2018

Carrying

Estimated

Carrying

Estimated

Value

    

Fair Value

    

Value

    

Fair Value

Non-qualified employee benefit plan investments

$

25

$

25

$

23

$

23

Forward swap contract related to the sale of investment in Venator

14

14

Interest rate contracts

(1)

(1)

Long-term debt (including current portion)

(2,336)

(2,504)

(2,320)

(2,403)

Schedule of assets and liabilities are measured at fair value on a recurring basis

The following assets and liabilities are measured at fair value on a recurring basis (dollars in millions):

Fair Value Amounts Using

Quoted prices

Significant other

Significant

in active markets

observable

unobservable 

September 30, 

for identical

inputs

 inputs

Description

    

2019

    

assets (Level 1)

    

(Level 2)

    

(Level 3)

Assets:

    

Equity securities:

Non-qualified employee benefit plan investments

$

25

$

25

$

$

Liabilities:

    

Derivatives:

Interest rate contracts

$

(1)

$

$

(1)

$

Fair Value Amounts Using

Quoted prices

Significant other

Significant

in active markets

observable

unobservable 

December 31, 

for identical

inputs

 inputs

Description

    

2018

    

assets (Level 1)

    

(Level 2)

    

(Level 3)

Assets:

Equity securities:

Non-qualified employee benefit plan investments

$

23

$

23

$

$

Derivatives:

Forward swap contract related to the sale of investment in Venator(1)

14

14

$

37

$

23

$

14

$

(1) In connection with the December 3, 2018 sale of Venator ordinary shares to Bank of America N.A., we recorded a forward swap. In February 2019, we settled this forward swap and received $16 million from the counterparty.